SPONSOR: Pouche
This bill requires insurers that provide coverage for epinephrine auto-injectors or prescription insulin drugs to limit the total amount that an insured is required to pay for a 30 day supply of covered epinephrine auto-injectors or prescription insulin drugs at an amount not to exceed $35 for insulin and $100 for epinephrine injectors, regardless of the quantity or type of covered prescription insulin drug used to fill the insured's prescription. The limit can increase yearly based on a percentage equal to the percentage change from the preceding year in the medical care component of the Consumer Price Index.
The Department of Commerce and Insurance, in conjunction with the Department of Health and Senior Services and the Department of Social Services, must make a report available to the public of findings from each department, as specified in the bill, by October 31, 2025.
The provisions of this bill terminate on January 1, 2026.
This bill is similar to HB 1632 (2024) and HCS HB 342 (2023).
Statutes affected: